Intratio
Quantitative Research
Skip to main content
AI Market Summary
Loading market intelligence...
AI 90-DAY FORECAST
NEUTRAL SIGNAL
██.█% Sign up free to reveal

Sera Prognostics, Inc. (SERA) AI Forecast

Our AI analyzed Sera Prognostics, Inc.. Create a free account to see the 90-day price prediction.

Free account • 30-day free trial

$SERA Neutral Signal Full forecast available

Sera Prognostics, Inc. (SERA) Stock Forecast 2025


Sera Prognostics, Inc. (SERA) AI Stock Price Forecast & Investment Analysis

Sera Prognostics, Inc. Stock Price Chart and Technical Analysis

Loading chart...

Sera Prognostics, Inc. (SERA) - Comprehensive Stock Analysis & Investment Research

Deep dive into Sera Prognostics, Inc.'s business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Analysis updated on March 10, 2026, 11:00 a.m. (UTC)

Sera Prognostics, Inc. Investment Summary

When evaluating whether Sera Prognostics, Inc. (SERA) represents a compelling investment opportunity, investors must consider multiple factors including the company's financial health, market position, growth prospects, and what our AI-powered predictive models suggest about its near-term price trajectory.

Company Profile

Sera Prognostics, Inc. (SERA) operates within the Industrial Applications and Services sector, specifically in the Services-Medical Laboratories industry. The company employs approximately 96 people. With a market capitalization of $88 million, the company is a small-cap stock that may offer higher growth potential but also carries higher volatility.

Financial Performance Analysis

Our comprehensive financial analysis covers Sera Prognostics, Inc.'s revenue, profitability metrics, balance sheet strength, and cash flow generation...

AI Price Predictions

Get AI-powered 7-day, 30-day and 90-day price forecasts for Sera Prognostics, Inc. along with confidence scores and detailed analysis...

Investment Considerations

Expert analysis of whether Sera Prognostics, Inc. is suitable for your investment objectives, risk tolerance, and time horizon...

Continue Reading Full Analysis

Get the complete investment breakdown for Sera Prognostics, Inc.

Sign Up Free
Corporate Identity

Sera Prognostics, Inc. (Stock Symbol: SERA) is a prominent company operating within the Industrial Applications and Services sector, with a specific focus on the Services-Medical Laboratories industry. The company's shares are publicly traded on the Nasdaq exchange.

Leadership & Workforce

Detailed information about Sera Prognostics, Inc.'s leadership team, workforce size, and organizational structure...

Market Classification

Market capitalization analysis and stock classification (mega-cap, large-cap, mid-cap, small-cap) for Sera Prognostics, Inc....

Sector & Industry Analysis

In-depth sector dynamics and industry context for Sera Prognostics, Inc....

Unlock Full Company Profile

Get complete details about Sera Prognostics, Inc.

Sign Up Free
Revenue & Growth Analysis
Profitability Metrics

Net profit margin, gross margin, and operating margin analysis for Sera Prognostics, Inc....

Market Valuation

P/E ratio, price-to-book, and valuation multiples for Sera Prognostics, Inc....

Return Metrics

Return on equity (ROE), return on assets (ROA), and capital efficiency for Sera Prognostics, Inc....

Unlock Financial Analysis

Get complete financial metrics for Sera Prognostics, Inc.

Sign Up Free
AI ANALYSIS AVAILABLE

Unlock Sera Prognostics, Inc.'s AI Price Forecast

Join 10,000+ investors using our 67%+ accurate AI predictions

4,000+ Stocks Analyzed
67%+ Accuracy Rate
Daily Updates
Start 30-Day Free Trial

30-day free trial • Cancel anytime

Strategic Market Position

Sera Prognostics, Inc. strategically competes in the highly dynamic Services-Medical Laboratories marketplace. As a small-cap company, it represents an emerging market participant with potentially significant growth opportunities. Small-caps often offer greater growth potential as they capture market share and scale their operations, though this comes with higher risk and volatility. Success at this stage can lead to substantial returns for early investors who identify winning business models.

Industry Competitive Landscape

Sera Prognostics, Inc. competes within the Industrial Applications and Services sector, navigating the competitive dynamics and market forces specific to this industry. The company's competitive position depends on its ability to differentiate through product quality, cost efficiency, customer relationships, or other strategic advantages relevant to its specific market segment.

Operational Efficiency

The company currently shows negative free cash flow of $-36 million . Negative free cash flow may reflect heavy investment in growth, working capital needs, or operational challenges. This is common for high-growth companies investing aggressively but warrants attention for mature businesses.

Financial Strength & Leverage

Current ratio of 15.76 demonstrates strong short-term liquidity with current assets significantly exceeding current liabilities. This provides a substantial buffer for meeting near-term obligations and handling unexpected financial needs.

Sera Prognostics, Inc. (SERA) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Sera Prognostics, Inc. stock analysis.

Deep dive into Sera Prognostics, Inc.'s financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if Sera Prognostics, Inc. stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For Sera Prognostics, Inc.: With a P/E ratio of -8.99, the market sees the stock as potentially undervalued.

P/E Ratio -8.99x
P/B Ratio 1.07x
Market Cap $88M
EPS $-0.85
Book Value/Share $2.13
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently Sera Prognostics, Inc. converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Sera Prognostics, Inc.: An ROE of -538.9% indicates room for improvement in shareholder value creation.

ROE -538.9%
ROA -41.4%
ROIC -315.7%
Net Margin -667.3%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess Sera Prognostics, Inc.'s ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For Sera Prognostics, Inc.: A current ratio of 15.76 indicates strong liquidity.

Current Ratio 15.76x
Quick Ratio 15.49x
D/E Ratio 0.01x
Financial Leverage 1.06x
Interest Coverage -91.2x
Working Capital $2M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal Sera Prognostics, Inc.'s ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For Sera Prognostics, Inc.: Free cash flow of $-36M indicates cash challenges that need attention.

Operating Cash Flow -$34M
Free Cash Flow -$36M
Capital Spending -$1M
CapEx/Sales 966.1%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively Sera Prognostics, Inc. uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For Sera Prognostics, Inc.:

Receivables Turnover 4.6x
Fixed Assets Turnover 0.1x
Days Sales Outstanding 80 days
Payables Period 6226 days
Understanding Financial Statement Data

What these metrics mean: Key figures from Sera Prognostics, Inc.'s income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For Sera Prognostics, Inc.:

Income Statement
Net Income -$29M
R&D Expense $15M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 81%
Cash & Short-term Investments 80%
Total Liabilities 6%
Short-term Debt 1%
Accounts Receivable 0%
Dividend & Shareholder Information
Shares Outstanding 39M
Growth Metrics (YoY)
EPS Growth -11.1%

Latest Sera Prognostics, Inc. Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting Sera Prognostics, Inc. (SERA) stock price and investment outlook.

📰 We are currently updating our news feed for Sera Prognostics, Inc.. Check back soon for the latest market analysis and company updates.

Sera Prognostics, Inc. Competitors & Peer Analysis - Industrial Applications and Services Sector

Comparative analysis of Sera Prognostics, Inc. against industry peers and competitors in the Industrial Applications and Services sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
Aclarion, Inc. ACON ██% $3M 0.0x 0.3x
Advanced Biomed Inc. ADVB ██% $7M 1.0x 0.7x
American Shared Hospital Services AMS ██% $14M 5.2x 0.6x
Biodesix Inc BDSX ██% $160M -3.0x 140.7x
Bionexus Gene Lab Corp BGLC ██% $5M x 0.8x
Burning Rock Biotech Ltd BNR ██% $0.00M x 0.0x
Caris Life Sciences, Inc. CAI ██% $5.37B 50.5x 9.3x
Caredx, Inc. CDNA ██% $903M 16.5x 3.0x
Celcuity Inc. CELC ██% $4.91B -4.5x 42.0x
Castle Biosciences Inc CSTL ██% $802M -2110.5x 1.7x
Quest Diagnostics Inc DGX ██% $23.52B 23.7x 3.3x
Exact Sciences Corp EXAS ██% $19.75B -343.6x 8.2x
First Choice Healthcare Solutions, Inc. FCHS ██% $130K x 0.0x
Fulgent Genetics, Inc. FLGT ██% $455M 516.8x 0.4x
Fortrea Holdings Inc. FTRE ██% $915M -6.8x 1.6x
Guardant Health, Inc. GH ██% $11.91B -8.9x 174.5x
Grail, Inc. GRAL ██% $2.01B x 0.9x
Labcorp Holdings Inc. LH ██% $22.17B 25.3x 2.6x
Ludwig Enterprises, Inc. LUDG ██% $6M x x
Mdxhealth Sa MDXH ██% $162M x x
Natera, Inc. NTRA ██% $27.68B -74.2x 16.2x
Capforce Inc. OPGN ██% $242M x 23.8x
Psychemedics Corp PMDI ██% $9M x 1.8x
Personalis, Inc. PSNL ██% $696M -2.3x 2.7x
Radnet, Inc. RDNT ██% $4.49B 462.8x 4.1x
Renalytix Plc RENXF ██% $13M x x
Renalytix Plc RNLXY ██% $511M x 73.4x
Sera Prognostics, Inc. SERA ██% $88M -9.0x 1.1x
Veracyte, Inc. VCYT ██% $2.69B 40.5x 2.1x
Exagen Inc. XGN ██% $74M -5.4x 4.1x
Reveal all forecasts See exact % predictions for all competitors
Sign up free

Frequently Asked Questions - Sera Prognostics, Inc. Stock Forecast

How accurate are Sera Prognostics, Inc. stock predictions?

Our AI model shows a -18% Spearman correlation coefficient for SERA predictions, based on advanced machine learning algorithms trained on over 10 years of market data. This measures the strength of the monotonic relationship between predicted and actual price movements.

What factors influence Sera Prognostics, Inc. stock price forecasts?

Our analysis considers Sera Prognostics, Inc.'s financial metrics, Industrial Applications and Services sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is Sera Prognostics, Inc. a good investment in 2025?

Based on our AI analysis, Sera Prognostics, Inc. shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are Sera Prognostics, Inc. forecasts updated?

Sera Prognostics, Inc. stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

My Portfolio

Investment Dashboard

Loading your portfolio...